Acurx Pharmaceuticals (ACXP) Tops Q4 EPS by 1c

Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q4 EPS of ($0.28), $0.01 better than the analyst estimate of ($0.29).

For earnings history and earnings-related data on Acurx Pharmaceuticals (ACXP) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Wall Street scrambles to lift Micron price targets ahead of earnings
• Citi sees this stock as primary lithium demand beneficiary, upgrades to Buy